Deferred Tax Assets, Valuation Allowance of COLLEGIUM PHARMACEUTICAL, INC from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
COLLEGIUM PHARMACEUTICAL, INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • COLLEGIUM PHARMACEUTICAL, INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $5,289,000, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

COLLEGIUM PHARMACEUTICAL, INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $5,289,000 -$1,209,000 -19% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $6,498,000 +$717,000 +12% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $5,781,000 +$527,000 +10% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $5,254,000 +$3,288,000 +167% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $1,966,000 -$63,695,000 -97% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $1,966,000 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $1,966,000 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q4 2020 $65,661,000 -$11,624,000 -15% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $77,285,000 -$3,005,000 -3.7% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $80,290,000 +$9,923,000 +14% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $70,367,000 -$6,196,000 -8.1% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $76,563,000 +$34,499,000 +82% 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q4 2015 $42,064,000 +$10,539,000 +33% 31 Dec 2015 10-K 07 Mar 2018 2017 FY
Q4 2014 $31,525,000 31 Dec 2014 10-K 18 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.